Immunotherapy drug made available for some NHS patients with advanced skin cancer after surgery

Grace Li                                                                                                             December 2nd, 2018
An immunotherapy drug will be made available to some patients with advanced melanoma skin cancer on the NHS in England. Nivolumab (Opdivo) will be an option for patients whose melanoma has spread to the lymph nodes or other organs and who have already had surgery, according to a recommendation from the National Institute for Health and Care Excellence (NICE). The drug works by boosting the immune system's ability to kill cancer cells and will be given to help target any cancer cells left behind after surgery. The current standard of care for these patients after surgery is monitoring to see if the cancer comes back.
See oirignal article at:



登錄 X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.